Evidence map›Paper›PMID 31267323›Full record

ReviewHeart failure reviews2020

Gender-related differences in heart failure: beyond the "one-size-fits-all" paradigm.

Annamaria De Bellis, Giulia De Angelis, Enrico Fabris, Antonio Cannatà, Marco Merlo, Gianfranco Sinagra

Abstract readReview
PubMed Publisher
In one paragraph

Review in Heart failure reviews, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Sexual Dimorphism in the Heart Failure Population.Anatolian journal of cardiology · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Annamaria De BellisCardiovascular Department, Azienda Sanitaria Universitaria Integrata and University of Trieste (ASUITs), Via P. Valdoni, 7, 34100, Trieste, Italy.
Giulia De AngelisCardiovascular Department, Azienda Sanitaria Universitaria Integrata and University of Trieste (ASUITs), Via P. Valdoni, 7, 34100, Trieste, Italy.
Enrico FabrisCardiovascular Department, Azienda Sanitaria Universitaria Integrata and University of Trieste (ASUITs), Via P. Valdoni, 7, 34100, Trieste, Italy.
Antonio CannatàCardiovascular Department, Azienda Sanitaria Universitaria Integrata and University of Trieste (ASUITs), Via P. Valdoni, 7, 34100, Trieste, Italy.
Marco MerloCardiovascular Department, Azienda Sanitaria Universitaria Integrata and University of Trieste (ASUITs), Via P. Valdoni, 7, 34100, Trieste, Italy. marco.merlo79@gmail.com.
Gianfranco SinagraCardiovascular Department, Azienda Sanitaria Universitaria Integrata and University of Trieste (ASUITs), Via P. Valdoni, 7, 34100, Trieste, Italy.
Azienda Sanitaria Universitaria Integrata di Trieste · ITUniversity of Trieste · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular diseases show many sex-related differences in prevalence, etiology, phenotype expression, and outcomes. Complex molecular mechanisms underlie this diverse pathological manifestation, from sex-determined differential gene expression to sex hormones interaction with their specific receptors in different tissues. More recently, differential non-coding RNAs regulation also turned out to be an involved mechanism. This review focuses on sex impact on the various heart failure syndromes, including coronary artery disease, heart failure with preserved ejection fraction and with reduced ejection fraction, with particular attention to dilated cardiomyopathy. Despite similar genetic predisposition in terms of identified causative mutations, other causes, such as cardiotoxic drugs exposure or stress-induced cardiomyopathy, are more prevalent in women. Beyond this, differences in disease presentation and natural history reveal a more severe clinical onset with otherwise better long-term outcomes in women compared to men. Understanding the varying characteristics of disease manifestation and outcomes is warranted for a prompt and tailored treatment for both men and women. This is a mandatory step in the road to the personalized medicine. Moreover, despite a higher enrollment in the last years, the under-representation of females in clinical trials is the first obstacle to overcome in the long way to develop appropriate sex-based therapy approach.

Indexed as

FemaleGlobal HealthHeart FailureHumansMaleMorbidityPrognosisRisk AssessmentRisk FactorsSex FactorsStroke VolumeVentricular Function, LeftDilated cardiomyopathyGenderHeart failureHFpEFHFrEFWomen

Identifiers

PMID31267323
OpenAlexW2955881747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.